Easywell Biomedicals, Inc. (TPEX:1799)

Easywell Biomedicals Revenue

Easywell Biomedicals had revenue of 236.70M TWD in the quarter ending March 31, 2026, with 56.19% growth. This brings the company's revenue in the last twelve months to 682.56M, up 10.35% year-over-year. In the year 2025, Easywell Biomedicals had annual revenue of 597.41M with 10.54% growth.

• Revenue (ttm): 682.56M
• Revenue Growth: +10.35%
• P/S Ratio: 6.07
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 4.15B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	597.41M	56.97M	10.54%
Dec 31, 2024	540.44M	268.81M	98.96%
Dec 31, 2023	271.63M	92.73M	51.83%
Dec 31, 2022	178.90M	-18.38M	-9.32%
Dec 31, 2021	197.28M	-70.38M	-26.29%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 25, 2026

Data Sources Report a data error